FDA Approves First Oral Peptide Pill for Plaque Psoriasis

A new once-daily pill just became the first FDA-approved oral peptide treatment for moderate-to-severe plaque psoriasis, offering hope to millions who've struggled with painful skin lesions.

The breakthrough medication cleared or nearly cleared skin in 70% of patients during clinical trials.